Activity
-
Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs – from ctla4 to pd1 to the next generations became a registered member 3 years, 5 months ago
Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs – from ctla4 to pd1 to the next generations became a registered member 3 years, 5 months ago